SCHEMBL691747

SCHEMBL691747

CC[C@@H](C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O

nearest known ligand 0.96

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.96
RCOR1 Q9UKL0 3/20 0.85
LDHB P07195 4/20 0.42
TERF2IP Q9NYB0 2/20 0.38
ESR1 P03372 2/20 0.37
ESR2 Q92731 1/20 0.37
KEAP1 Q14145 1/20 0.36
NPY1R P25929 1/20 0.36
NPY2R P49146 1/20 0.36
NPY4R P50391 1/20 0.36
NPY5R Q15761 1/20 0.36
JAK1 P23458 1/20 0.35
CTNNB1 P35222 1/20 0.35
STAT1 P42224 1/20 0.35
F11 P03951 2/20 0.35
EGFR P00533 1/20 0.34
LCK P06239 1/20 0.34
TERF2 Q15554 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24437319 1.00 KDM1A (0.96) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL16549279 1.00 KDM1A (0.96) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL29360957 1.00 KDM1A (0.96) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL1979092 1.00 KDM1A (0.96) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL29380446 1.00 KDM1A (0.96) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL31066574 0.98 KDM1A (1.00) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL49226 0.98 KDM1A (1.00) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL18902532 0.98 KDM1A (1.00) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL21476977 0.98 KDM1A (1.00) KDM1ARCOR1LDHBTERF2IPESR1
SCHEMBL21474097 0.97 KDM1A (0.99) KDM1ARCOR1LDHBTERF2IPESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118340751-A Colistin sensitizer and application thereof in resisting escherichia coli 武汉大学 2024-07-16 CN claimed
CN-117860741-A Application of SU3327 in preparation of anti-vibrio parahaemolyticus drug 中国农业大学 2024-04-12 CN claimed
CN-114885950-B Application of colistin sulfate in pest control 岭南现代农业科学与技术广东省实验室 2023-03-24 CN claimed
CN-115227653-A Colistin sulfate soluble powder for treating intestinal infection of livestock and poultry and preparation method thereof 河南创鑫生物科技有限公司 2022-10-25 CN claimed
CN-114885950-A Application of colistin sulfate in pest control 岭南现代农业科学与技术广东省实验室 2022-08-12 CN claimed
CN-216725963-U A deposit extraction element for production of colistin sulfate 山东普斯曼生物科技有限公司 2022-06-14 CN claimed
CN-114514033-A Drug development 赫尔普百治疗有限公司 2022-05-17 CN claimed
CN-113995719-A Application of sodium carboxymethylcellulose in improvement of amoxicillin and colistin sulfate injection 河南中盛动物药业有限公司 2022-02-01 CN claimed
CN-210340734-U A elution system for colistin sulfate 河北圣雪大成唐山制药有限责任公司 2020-04-17 CN claimed
CN-110101837-A A kind of veterinary composition and its liquid preparation and preparation method 四川伴农动保生物技术有限公司 2019-08-09 CN claimed
US-20100028938-A1 METHOD OF SCREEING FOR PATHOGENS OXOID LIMITED (GB) 2010-02-04 US claimed
WO-2006045156-A1 THERAPY FOR MULTI-DRUG RESISTANT MICROORGANISMS MONASH UNIVERSITY (AU) 2006-05-04 WO claimed
EP-0998580-B1 CULTURE MEDIUM FOR DETECTING PATHOGENIC BACTERIA OF THE GENUS LISTERIA AND METHOD FOR IDENTIFYING SAID BACTERIA BIO RAD PASTEUR (FR) 2006-04-05 EP claimed
US-6673054-B1 Body protection article having a gelatinous material with a therapeutic additive SILIPOS INC. 2004-01-06 US claimed
US-6521213-B1 Administering mixtures of lipids, surfactants, dispersants, propellants and drugs such as antibiotics, bactericides, viricides and fungicides to the ears; protective coatings that reduce surface tension of the air/liquid interfaces SCIENTIFIC DEVELOPMENT AND RESEARCH, INC. 2003-02-18 US claimed
US-6228606-B1 NUTRITIVE AGAR INCLUDES SYNTHETIC CHROMOGENIC SUBSTRATE FOR PHOSPHOLIPASE C SPECIFIC OF PHOSPHATIDYLINOSITOL; DIRECT DETECTION OF LISTERIA PASTEUR SANOFI DIAGNOSTICS (FR) 2001-05-08 US claimed
EP-0489096-B1 PHARMACEUTICAL COMPOSITIONS AND A DEVICE FOR ADMINISTERING THE SAME BIOGLAN IRELAND R & D LTD (IE) 1995-11-15 EP claimed
US-5437872-A Tablets or lozenges releasable by patient's saliva; mixture of two or more nonabsorbent antibiotics BIOGLAN LABORATORIES LTD. (GB) 1995-08-01 US claimed
EP-0489096-A1 PHARMACEUTICAL COMPOSITIONS AND A DEVICE FOR ADMINISTERING THE SAME. BIOGLAN LAB LTD (GB) 1992-06-10 EP claimed
WO-1991002518-A1 PHARMACEUTICAL COMPOSITIONS AND A DEVICE FOR ADMINISTERING THE SAME BIOGLAN LABORATORIES LTD. (GB) 1991-03-07 WO claimed